Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva

Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva

Submitted by admin on March 20, 2019 - 12:16pm
Source: 
Pharmaceutical Business Review
News Tags: 
Novo Nordisk
Teva Pharmaceutical
patents
Victoza
diabetes
Headline: 
Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
snippet: 


A settlement between Novo Nordisk and Teva Pharmaceuticals USA (Teva) has been reached on the US patent litigation case for Victoza (liraglutide).

Do Not Allow Advertisers to Use My Personal information